Clinical Trials Directory

Trials / Completed

CompletedNCT02473315

Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Whole body cryotherpy (WBC) is a well-tolerated procedure that implies patients' exposition at a temperature of approximately -110 degrees. A considerable increase in the popularity of WBC has occurred in rheumatologic patients, despite a lack of evidences of its efficiency. Because of its interesting anti-inflammatory properties, the investigators think that WBC could be an alternative treatment to classical NSAIDs (Non Steroidal Anti Inflammatory Drugs) and corticosteroids, in patients suffering from axial spondyloarthritis. This is a proof of concept study.

Conditions

Interventions

TypeNameDescription
OTHERcryotherapyThe treatment arm :Whole body cryotherpy (WBC) (20 sessions of 3 minutes at a temperature of -110 degrees Celsius, on the basis of two sessions a day, spread over two weeks). The control arm : Whole body cryotherpy (WBC) (20 sessions of 1 minute at a temperature of -60 degrees Celsius, on the basis of two sessions a day, spread over two weeks).

Timeline

Start date
2016-07-01
Primary completion
2018-09-18
Completion
2022-10-28
First posted
2015-06-16
Last updated
2022-11-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02473315. Inclusion in this directory is not an endorsement.

Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis (NCT02473315) · Clinical Trials Directory